Astragaloside IV improves the pharmacokinetics of febuxostat in rats with hyperuricemic nephropathy by regulating urea metabolism in gut microbiota

Hyperuricemic nephropathy (HN) is a common clinical complication of hyperuricemia. The pathogenesis of HN is directly related to urea metabolism in the gut microbiota. Febuxostat, a potent xanthine oxidase inhibitor, is the first-line drug used for the treatment of hyperuricemia. However, there have...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhen Xiong, Tang, Xiao Hui, Jiang, Sheng Lu, Pang, Jia Qian, Xu, Yu Bin, Yuan, Dan Dan, Zhang, Ling Ling, Liu, Hui Min, Fan, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807765/
https://www.ncbi.nlm.nih.gov/pubmed/36605404
http://dx.doi.org/10.3389/fphar.2022.1031509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807765/
https://www.ncbi.nlm.nih.gov/pubmed/36605404
http://dx.doi.org/10.3389/fphar.2022.1031509

Ejemplares similares